IL-17 inhibitors

IL-17 inhibitors target the protein called interleukin-17 (IL-17). 

These biologics target either the I L-17 ligand or its receptor.

IL-17 is a cytokine, which is a type of signaling molecule involved in inflammation and immune response. 

IL-17 plays a role in various autoimmune diseases, such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease.

IL-17 inhibitors work by blocking the activity of IL-17, which helps to reduce inflammation and prevent further damage to the body tissues. 

These drugs effective in treating psoriasis, psoriatic arthritis, and ankylosing spondylitis.

Some examples of IL-17 inhibitors include secukinumab, ixekizumab, bimekizumab, and brodalumab. 

These drugs are typically administered by injection.

Leave a Reply

Your email address will not be published. Required fields are marked *